Publication | Closed Access
Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice
62
Citations
18
References
2015
Year
ObesityMetabolic SyndromeDiabetes ManagementMedicineInsulin ManagementDiabetesObese Type 2Diabetic Db/db MiceSglt2 Inhibitor LuseogliflozinDiabetes MellitusPharmacologyCell BiologyCell SignalingInsulin Signaling
| Year | Citations | |
|---|---|---|
Page 1
Page 1